Language selection

Search

Patent 1059137 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1059137
(21) Application Number: 247190
(54) English Title: PROCESS FOR THE PREPARATION OF THERAPEUTICALLY VALUABLE 2-OXO-1-PYRROLIDINYLACETAMIDE
(54) French Title: PROCEDE POUR LA PREPARATION D'UN PRODUIT UTILISABLE EN PHARMACOPEE, DE TYPE 2-OXO-1-PYRROLIDINYLACETAMIDE
Status: Expired
Bibliographic Data
Abstracts

English Abstract




ABSTRACT OF THE DISCLOSURE
An improved process is provided for the preparation of piracetam
(2-oxo-1-pyrrilidinylacetamide) involving a ring colsure reaction on N-
carbamoylmethyl-4-aminobutryric acid ethyl ester being the simple expedient
of heating. This procedure obviates the use of dangerous raw materials.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. In a process for the preparation of 2-oxo-1-pyrrolidinylace-

tamide, a therapeutically valuable compound of the formula

Image

the step which comprises heating an amino acid ester of the formula

Image

thereby to split off ethanol and to cyclize said amino acid ester.
2. The process of claim 1 wherein the heating is at a temperature
of 160 - 180°C.
3. A process for the preparation of 2-oxo-pyrrolidinylacetamide,
a therapeutically valuable compound of the formula




Image

which comprises: boiling glycinamide hydrochloride and 4-chlorobutyric acid
ethyl ester together in an organic solvent in the presence of an acid bind-
ing agent and a catalytic amount of potassium iodide, thereby to form an
amino acid ester of the formula



Image

and then heating said compound to a temperature of 160 - 180°C., thereby to


split off ethanol and to cyclize said amino acid ester.



4. The process of claim 3 wherein the organic solvent is an al-
cohol and the acid binding agent is sodium carbonate.
5. The process of claims 3 or 4 including the step of simutane-
ously distilling off split-off ethanol as it is formed.
6. In the process for the preparation of a therapeutically valua-
ble compound of the formula



Image

the improvement which comprises preliminary step of forming formula

Image

by reacting glycinamide hydrochloride with 4-chlorobutyric acid ethyl ester.
7. The process of claim 6 wherein said reaction is carried out
by boiling glycinamide hydrochloride and 4-chlorobutyric acid ethyl ester in
an organic solvent in the presence of an acid binding agent and a catalytic
amount of potassium iodide.
8. The process of claim 7 wherein the organic solvent is alcohol,
and the acid binding agent is sodium carbonate.
9. The compound

Image

whenever prepared by the-process of claims 6, 7 or 8 or by their obvious

chemical equivalents.



Description

Note: Descriptions are shown in the official language in which they were submitted.


-- 1059137

m is invention relates to a new p~ocess for the preparation of
2-oxo-1-pyrrilidinylacetamide or piracetam, namely a compound having the
formula

~, .
CH2-C0-NH2 , and to the intermediates used to
produce such compound.
Piracetam is a so-called cerebrotonicum, which is used for in- -
stance in travel sickness and the therapy of locomotorial diseases, hyper-
tension and epilepsy. It is widely used also in geriatry for improving
cerebral activity. m e use of piracetam is thus very wide and the toxicity
is 1c~7.
The preparation of piracetam has previously been described, e.g.
in U.S. Patent No. 3,459,738 issued Aug. 5, 1969 to Henri ~orren, Forest,
Belgium, assign~r to UCB (Union Chimique-Chemische Eedrijven), Saint-
Gilles-Br~ssels, Belgium, wherein it is prepared either from the correspond- t
ing ester and ammonia or by reacting a metal salt of 2-oxo-pyrrolidine ~7ith r
chloroacetamide.
In the above identified U.S. Patent, the procedure commences either
from the alk~li metal salt of 2-ox~pyrrolidine or from 2-oxo-1-pyrrolidinyl-
acetic acid ester, which is prepared from the above mentioned aIkali salt
and chloroacetic acid ester. In the preparation of the sodium salt of 2-
oxopyrrolidine, either metallic sodium or sodium amide are used, and in
the synthesis of the amide from the ester, gaseous ammDnia is used. m us,
the process of the above identified U.S. Patent involves the use of danger-
ous raw 7naterials.
It would therefore be desirable to provide a process for the
preparation of piracetam which does not inv~lve the use of dangerous raw
material~. According to a broad aspect of the present invention, the
~uç--et n is prepared by ring closure reaction. By one variant, glycina-



i7, ~'


,.~

. ' '

~059137

mide hydrochloride is first reacted with 4-chlorobutyric acid ethyl ester
formung N-carbamoyLmet hyl-4-aminoputyric acid ethyl ester, which is a new
compound, which is then cvclized to piracetam by heating.
Thus, by~ a broad aspect of this invention an inçrovement is pro-
vided in a process for the preparation of piracetam (2-oxo-1-pyrrolidinyl-
acetamide), a therapeutically valuahle compound of the formula

-0
N -

Cil2 -CO-NH2
the step which comprises heating an amino acid ester of the form~la

CH2-CO-NH
~I ~ `,
\ CH2-CH2-CH2{0CC2H5,
thereby to split off ethanol and to cyclize the amino acid ester.
By one variant, the heating is at a temperature of 1~0 - 180C.
By anoth.er aspect, a process is provided for the preparation of
2-oxo-1-pyrrolidinylacetamide, a therapeutically valuable oompound of the
formula
~0 ~,,

CH2 -CO-NU2

which oomprises: boiling glycinamide hydrochloride and 4-chlorobutyric acid
ethyl ester together in an organic solvent in the presence of an acid binding
agent and a catalytic amount of potasslum iodide, thereby to form an amino
acid ester of the formula




, S,
. .
~,
:, , , ': , . ~, . . - , ,. . ;


' ;' ., ~ '

:' . . . , :, :. -
., : :

~`` 1059137

/ C 2 2
`
CH2-CH2-CH2-CC2H5;
and then heating the can?ound to a temperature of 160 - 180C, thereby to
split off ethanol and to cyclize the am mo acid ester.
By one variant, the organic solvent is an alcohol and the acid
binding agent is sodium carbonate.
By a variation thereof, the process includes the step of simul-
taneously distilling off split-off ethanol as it is formed.
In another aspect of the invention the N-carbamoylmethyl-4-amino-
butyric acid ethyl ester is prepared by reacting glycinamide hydrochloride
with 4-chlorobutyric acid. r
By a variant thereof, the reaction is carried out by boiling
glycinamide hydrochloride and 4-chlorobutyric acid ethyl ester in an organic
solvent in the presence of an acid binding agent and a catalytic amount of
potassium iodide.
- By a variation thereof, the organic solvent is alcohol, and the
acid binding agent is sodium carbonate. r
m e N-carbamoylmethyl-4-amino butyric acid ethyl ester is a new
con~ound providing another aspect of this invention.
From textbooks in chemistry (e.g. Houben-hTeyl: Methoden der
organischen Chemie, Stickstoffverbindungen II/III, Georg Thieme Verlag,
Stuttgart 1958, p. 529), it is known that amino acids, their esters, amides
and nitriles can be cyclized to lactames. Hcwever, the reactions of N-
substituted amino acids have not been studied much. m e process of a broad
aspect of this invention is thus to be considered a new ~7ay to sol~e the
~ piracetam synthesis. m e reaction scheme of the process of an aspect of
; this invention is the folla~7ing:



.. ...

` ~ 1059137

H2N-CH2-CO-~H2.HCl~Cl- OE 2-CH2-CH2 ~00C2H5
,,
CH -CO-NH '
Na2C3
~ N~ heating >
CH2-CH2-CH2-CO~c2H5
(I) ~
r

I _L O +C2H5H
'Nr

C1~2-CO-NH2
me intermediate I is a new oompound, which has not earlier been
described in the literature. Glycinamide hydrochloride and 4-chiorobutyric
acid ethyl ester are industrial raw materials. The reaction between them
is simple: the agents are boiled in an organic solvent, preferably an
alcohol, e.g. ethanol, in the presence of an equivalent am~unt of sodium
carbonate and a catalytic amount of potassium iodide. The formed inter- ~
mediate I can be heated to a temperature of 160 - 180C, without isolation t
of the pure product, which leads to ring closure. m e process is conse-
20 quently simple in its entirety and the yield is good.
The prncess of broad aspects of the invention has, when oompared
to the above identified U.S. Patent, the advantage that no dangerous raw ~ -
materials being used. m e process according to aspects of this invention
can therefore be carried out with remarkably simpler equipment.
The invention is illustrated by the following exa~ple:
Example 1
22.1 g of glycinamide hydrochloride, 30.1 g of 4-chlorobutyric -
acid ethyl ester, 21.2 g of sodium carbonate and 0.5 g of potassium iodide
i are refluxed in 100 ml of ethanol. ~hen the reaction is oompleted after

~h ~ - 3 a -



, .

':. , '' ' , : '
' ' , ' : ''','., . '": .''~,,.~'," ' ' '',, ' ,
, . . . .

~ 1059137

16 hours, the suspension is filtered and the ethanol is distilled off.
m e residue, 34.2 g (9. per cent), is composed of crude N-carb~mDylmethyl-
4-aminobutyric acid ethyl ester. This is a solid agent having a melting
point of 100 - 115C, but it has never been obtained in a quite pure state r
as it always contains small am~unts of piracetam.
The residue can be used in the foll~^~ing step without isolation.
It is heated to 170C. and the formed ethanol is distilled off. m e heating
is oontinued so long as ethanol distils over, then is cooled and crystallized r
from isopropanol. Yield 21.7 g of piracetam (total yield 76.4%). The
melting point is 150 - 152C. t

~,




,.
: ~ - 3 b -

Representative Drawing

Sorry, the representative drawing for patent document number 1059137 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1979-07-24
(45) Issued 1979-07-24
Expired 1996-07-24

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MEDIPOLAR OY
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 1994-04-23 5 170
Drawings 1994-04-23 1 6
Claims 1994-04-23 2 58
Abstract 1994-04-23 1 12
Cover Page 1994-04-23 1 17